Zika: Assocation studies with Guillain-Barre syndrome and neurotropism.

Lead Research Organisation: University of Glasgow

Abstract

Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.

Technical Summary

The recent global outbreak of Zika virus infection has been linked to severe neurological
phenotypes affecting the peripheral and central nervous systems. While these relationships
are currently undergoing epidemiological monitoring, it seems prudent to assume that these
associations will be confirmed (Cao-Lormeau VM et al., Lancet 2016, in press). In
anticipation, this study will investigate the underlying causation of neurological deficits,
focusing on Guillan-Barré syndrome (GBS); generally considered an autoantibody-mediated
disorder. What is not clear in the current epidemic is whether Zika-GBS is due to direct
infection of neural cells or a post-infectious autoimmune syndrome. We are poised to begin
work to examine the effects immediately of (i) direct viral infection, and shortly of (ii)
humoral factors in serum from Zika-associated GBS and control cases (currently being
obtained with consent from Recife, Brazil by Willison/Kohl), on neural cell viability and
function, using physiologically intact murine living peripheral nerve preparations and cultured
neurons and Schwann cells. Comparative cultures of murine CNS cells will be examined in
parallel to gain insights into the CNS/PNS distinctions in neurological complications. Further,
human sera will be screened to idenitfy autoantibodies to antigens associated with
conventional GBS, to facilitate diagnosis. Once Catergory 3 permissions are granted, we will
substantiate relevant findings in vivo. These studies will lead to a deeper understanding of
the nature of Zika-associated GBS and allow treatment and diagnostic strategies to be
developed.

Publications

10 25 50
 
Description Repsonse mode
Amount £140,000 (GBP)
Funding ID 203680/Z/16/Z 
Organisation Wellcome Trust 
Sector Charity/Non Profit
Country United Kingdom
Start 04/2016 
End 12/2017
 
Description Zika-PLAN, EU funded Framework 2020 project 
Organisation European Commission
Country European Union (EU) 
Sector Public 
PI Contribution Member
Collaborator Contribution Lead for WP4, member for WP2
Impact Multidisciplinary
Start Year 2016